Pierre D. T.
- Country
- France
- Department
- Maladies Infectieuses
Research Overview
- Evaluation of Safety in HBV Virological Control Using Darunavir, Ritonavir, Dolutegravir Sodium, and Lamivudine in HIV-1/HBV Co-infected Patients
- Phase II Pilot Study on Dual Antiretroviral Therapy with Long-Acting Cabotegravir and Lenacapavir in HIV-Infected Patients
- Comparative Study of Doravirine/Lamivudine Versus Dolutegravir/Lamivudine for Maintenance Therapy in HIV Patients with Suppressed Viral Load
Data & Insights
Has run more than one trial at 15 of 43 partner sites.
Specializations
HIV Treatment Innovation
This investigator specializes in advancing antiretroviral therapy approaches, with particular focus on evaluating novel two-drug regimens for HIV management. Their research explores the effectiveness of treatments including DOR/3TC and DTG/3TC combinations in maintaining virological control.
- Viral Load Suppression Strategies
- Treatment Optimization Studies
- Long-acting Antiretroviral Therapies
Their work extends to investigating innovative long-acting therapeutics including cabotegravir and lenacapavir combinations.
HIV-HBV Coinfection Management
The investigator conducts research in the complex field of HIV-HBV coinfection, examining treatment reduction strategies while maintaining viral control. Their work focuses on optimizing therapeutic approaches for patients with dual viral infections.
- Antiviral Treatment Strategies
- Viral Control Monitoring
- Treatment Safety Assessment
Research emphasis includes evaluating long-term safety and efficacy of modified treatment regimens in coinfected patients.
Immunotherapeutic Approaches
The investigator explores advanced immunological treatments for HIV, particularly focusing on broadly neutralizing antibodies (bNAbs) in combination with conventional therapy. Their research examines innovative approaches for achieving HIV remission.
- Primary HIV Infection Treatment
- Antibody-based Therapies
- Post-treatment Control Studies
Special attention is given to investigating dual long-acting HIV-specific antibody treatments in newly diagnosed cases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.